 Michael Yaron
Concepts (613)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sjogren's Syndrome | 17 | 2001 | 41 | 1.830 |
Why?
| | Arthritis, Rheumatoid | 44 | 2006 | 1003 | 1.650 |
Why?
| | Altitude Sickness | 9 | 2015 | 172 | 1.230 |
Why?
| | Methotrexate | 15 | 1997 | 226 | 0.910 |
Why?
| | Synovial Membrane | 10 | 2003 | 75 | 0.890 |
Why?
| | Osteoarthritis | 12 | 2003 | 171 | 0.890 |
Why?
| | Saliva | 7 | 2001 | 188 | 0.860 |
Why?
| | Interleukin-1 | 11 | 2004 | 966 | 0.780 |
Why?
| | Hyaluronic Acid | 12 | 2001 | 190 | 0.760 |
Why?
| | Balneology | 4 | 2000 | 4 | 0.510 |
Why?
| | Antibodies, Antinuclear | 7 | 2001 | 58 | 0.510 |
Why?
| | Middle Aged | 86 | 2015 | 26737 | 0.490 |
Why?
| | Interleukin-6 | 6 | 2006 | 676 | 0.480 |
Why?
| | Surveys and Questionnaires | 7 | 2010 | 4623 | 0.480 |
Why?
| | Female | 114 | 2015 | 59518 | 0.450 |
Why?
| | Calcium, Dietary | 1 | 2014 | 55 | 0.450 |
Why?
| | Communication Barriers | 2 | 2007 | 89 | 0.440 |
Why?
| | Endothelium | 1 | 2014 | 111 | 0.440 |
Why?
| | Nitric Oxide | 4 | 2003 | 823 | 0.410 |
Why?
| | Arthritis, Psoriatic | 5 | 2000 | 16 | 0.410 |
Why?
| | Altitude | 5 | 2004 | 432 | 0.410 |
Why?
| | Fibromyalgia | 4 | 2009 | 56 | 0.400 |
Why?
| | Humans | 153 | 2015 | 114696 | 0.400 |
Why?
| | Arteries | 1 | 2014 | 247 | 0.400 |
Why?
| | Male | 90 | 2015 | 55604 | 0.390 |
Why?
| | Aged | 55 | 2015 | 19074 | 0.380 |
Why?
| | Adult | 72 | 2015 | 30552 | 0.380 |
Why?
| | Low Back Pain | 3 | 1998 | 95 | 0.370 |
Why?
| | Rheumatic Diseases | 2 | 2010 | 49 | 0.360 |
Why?
| | Dietary Supplements | 1 | 2014 | 460 | 0.350 |
Why?
| | Medical Order Entry Systems | 1 | 2010 | 41 | 0.330 |
Why?
| | Travel | 2 | 2008 | 121 | 0.320 |
Why?
| | Gold | 6 | 1997 | 106 | 0.320 |
Why?
| | Israel | 11 | 2010 | 40 | 0.310 |
Why?
| | Prostaglandins E | 6 | 1993 | 44 | 0.310 |
Why?
| | Physical Examination | 3 | 2015 | 222 | 0.310 |
Why?
| | Antirheumatic Agents | 5 | 2006 | 255 | 0.300 |
Why?
| | Aurothioglucose | 3 | 1997 | 6 | 0.300 |
Why?
| | Drug Eruptions | 3 | 1997 | 26 | 0.300 |
Why?
| | Knee Joint | 5 | 2003 | 323 | 0.290 |
Why?
| | Sleep Wake Disorders | 2 | 2004 | 233 | 0.290 |
Why?
| | Severity of Illness Index | 4 | 2007 | 2540 | 0.290 |
Why?
| | Spondylitis, Ankylosing | 4 | 2007 | 43 | 0.280 |
Why?
| | Matrix Metalloproteinase 3 | 2 | 2006 | 23 | 0.280 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 6 | 2003 | 299 | 0.280 |
Why?
| | Child Behavior | 2 | 2007 | 219 | 0.270 |
Why?
| | Professional-Family Relations | 1 | 2008 | 133 | 0.270 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2004 | 1140 | 0.270 |
Why?
| | Penicillamine | 5 | 1991 | 22 | 0.260 |
Why?
| | Child Welfare | 1 | 2008 | 192 | 0.260 |
Why?
| | Wilderness | 2 | 2015 | 14 | 0.260 |
Why?
| | Length of Stay | 1 | 2010 | 962 | 0.250 |
Why?
| | Lupus Erythematosus, Systemic | 9 | 2003 | 219 | 0.250 |
Why?
| | Sensitivity and Specificity | 7 | 2010 | 1693 | 0.240 |
Why?
| | Receptors, Interleukin-2 | 3 | 2000 | 64 | 0.240 |
Why?
| | Tomography, X-Ray Computed | 8 | 1998 | 2286 | 0.240 |
Why?
| | Health Education | 1 | 2008 | 323 | 0.240 |
Why?
| | Emergency Service, Hospital | 3 | 2010 | 1818 | 0.230 |
Why?
| | Heat Stroke | 1 | 2004 | 6 | 0.220 |
Why?
| | Population Surveillance | 1 | 2007 | 392 | 0.220 |
Why?
| | Hydroxybutyrates | 1 | 2003 | 11 | 0.220 |
Why?
| | Osteoarthritis, Knee | 2 | 2003 | 213 | 0.220 |
Why?
| | Phytotherapy | 1 | 2003 | 66 | 0.210 |
Why?
| | Aniline Compounds | 1 | 2003 | 70 | 0.210 |
Why?
| | Cervical Vertebrae | 2 | 1995 | 104 | 0.210 |
Why?
| | Anthraquinones | 2 | 2000 | 9 | 0.210 |
Why?
| | Fibroblasts | 7 | 1993 | 838 | 0.210 |
Why?
| | Prednisone | 8 | 2003 | 229 | 0.210 |
Why?
| | Osteonecrosis | 2 | 1996 | 18 | 0.200 |
Why?
| | Respiration | 1 | 2003 | 180 | 0.200 |
Why?
| | Prospective Studies | 15 | 2004 | 6220 | 0.200 |
Why?
| | Wounds and Injuries | 5 | 2015 | 749 | 0.200 |
Why?
| | Mud Therapy | 3 | 2000 | 3 | 0.200 |
Why?
| | Plant Extracts | 1 | 2003 | 154 | 0.190 |
Why?
| | Receptors, Interleukin-1 | 2 | 2001 | 228 | 0.190 |
Why?
| | Dinoprostone | 2 | 1999 | 184 | 0.190 |
Why?
| | Hydroxychloroquine | 2 | 1999 | 54 | 0.190 |
Why?
| | Minocycline | 5 | 1999 | 26 | 0.190 |
Why?
| | Guanidines | 1 | 2001 | 33 | 0.190 |
Why?
| | Retinal Hemorrhage | 1 | 2001 | 18 | 0.180 |
Why?
| | Back Pain | 3 | 2000 | 44 | 0.180 |
Why?
| | Hand | 5 | 2001 | 134 | 0.180 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2014 | 1842 | 0.180 |
Why?
| | Pulmonary Edema | 1 | 2001 | 115 | 0.180 |
Why?
| | Nitric Oxide Synthase | 1 | 2001 | 209 | 0.170 |
Why?
| | Arthritis, Juvenile | 2 | 1992 | 42 | 0.170 |
Why?
| | Aged, 80 and over | 13 | 2010 | 6347 | 0.170 |
Why?
| | Amitriptyline | 1 | 1999 | 21 | 0.170 |
Why?
| | Adrenal Cortex Hormones | 3 | 1999 | 497 | 0.170 |
Why?
| | Emergency Treatment | 2 | 2004 | 113 | 0.170 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2008 | 1183 | 0.170 |
Why?
| | Synovial Fluid | 2 | 1989 | 56 | 0.170 |
Why?
| | Calcinosis | 3 | 1998 | 242 | 0.170 |
Why?
| | Fluoxetine | 1 | 1999 | 46 | 0.170 |
Why?
| | Biomarkers | 12 | 2000 | 3408 | 0.160 |
Why?
| | Resuscitation | 2 | 1994 | 252 | 0.160 |
Why?
| | Immunosuppressive Agents | 1 | 2003 | 646 | 0.160 |
Why?
| | Tears | 1 | 1998 | 14 | 0.160 |
Why?
| | Down-Regulation | 1 | 2001 | 594 | 0.160 |
Why?
| | Antiphospholipid Syndrome | 2 | 1998 | 26 | 0.150 |
Why?
| | Analgesia, Epidural | 1 | 1998 | 20 | 0.150 |
Why?
| | Eye Proteins | 1 | 1998 | 70 | 0.150 |
Why?
| | Cross-Over Studies | 2 | 2014 | 440 | 0.150 |
Why?
| | Pain Measurement | 5 | 2004 | 444 | 0.150 |
Why?
| | Enzyme Inhibitors | 1 | 2001 | 750 | 0.150 |
Why?
| | Disasters | 1 | 1999 | 88 | 0.150 |
Why?
| | Hypoxia | 1 | 2004 | 958 | 0.140 |
Why?
| | Acute Disease | 6 | 2007 | 911 | 0.140 |
Why?
| | Osteoporosis | 2 | 1999 | 226 | 0.140 |
Why?
| | RNA, Small Cytoplasmic | 1 | 1997 | 6 | 0.140 |
Why?
| | Ultraviolet Rays | 1 | 2000 | 363 | 0.140 |
Why?
| | Bronchial Spasm | 1 | 1996 | 4 | 0.140 |
Why?
| | Anti-Inflammatory Agents | 4 | 2003 | 447 | 0.140 |
Why?
| | Mortality | 1 | 1999 | 287 | 0.140 |
Why?
| | Disabled Persons | 2 | 2015 | 134 | 0.140 |
Why?
| | Capnography | 1 | 1996 | 11 | 0.140 |
Why?
| | Antibodies, Antiphospholipid | 1 | 1996 | 21 | 0.140 |
Why?
| | Sulfasalazine | 2 | 1997 | 21 | 0.130 |
Why?
| | Autoimmune Diseases | 4 | 2000 | 382 | 0.130 |
Why?
| | C-Reactive Protein | 5 | 1999 | 362 | 0.130 |
Why?
| | Rheumatoid Nodule | 3 | 2001 | 6 | 0.130 |
Why?
| | Thermometers | 1 | 1995 | 6 | 0.130 |
Why?
| | Eicosanoids | 1 | 1996 | 54 | 0.130 |
Why?
| | Brown-Sequard Syndrome | 1 | 1995 | 5 | 0.130 |
Why?
| | Thermography | 1 | 1995 | 11 | 0.130 |
Why?
| | Tympanic Membrane | 1 | 1995 | 20 | 0.130 |
Why?
| | Cyanoacrylates | 1 | 1995 | 4 | 0.120 |
Why?
| | Medical History Taking | 1 | 2015 | 114 | 0.120 |
Why?
| | Mountaineering | 3 | 2008 | 47 | 0.120 |
Why?
| | HLA Antigens | 5 | 1991 | 225 | 0.120 |
Why?
| | Tissue Adhesives | 1 | 1995 | 16 | 0.120 |
Why?
| | Joint Deformities, Acquired | 2 | 2000 | 10 | 0.120 |
Why?
| | Creatinine | 3 | 2014 | 425 | 0.120 |
Why?
| | Foot Ulcer | 1 | 1995 | 5 | 0.120 |
Why?
| | Jews | 5 | 2009 | 18 | 0.120 |
Why?
| | Colitis, Ulcerative | 1 | 1996 | 105 | 0.120 |
Why?
| | HLA-DR Antigens | 2 | 1994 | 219 | 0.120 |
Why?
| | Lacerations | 1 | 1995 | 27 | 0.120 |
Why?
| | Hand Injuries | 1 | 1995 | 33 | 0.120 |
Why?
| | Fever | 2 | 1996 | 280 | 0.120 |
Why?
| | Hospital Design and Construction | 1 | 1994 | 3 | 0.120 |
Why?
| | Administration, Oral | 3 | 2014 | 728 | 0.120 |
Why?
| | Cartilage, Articular | 3 | 2001 | 289 | 0.120 |
Why?
| | Glycosaminoglycans | 2 | 1999 | 79 | 0.120 |
Why?
| | Joints | 4 | 2004 | 84 | 0.120 |
Why?
| | Hypersensitivity | 1 | 1998 | 252 | 0.120 |
Why?
| | Wounds, Penetrating | 1 | 1995 | 73 | 0.120 |
Why?
| | Cells, Cultured | 7 | 2003 | 3886 | 0.110 |
Why?
| | Recommended Dietary Allowances | 1 | 2014 | 18 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2003 | 797 | 0.110 |
Why?
| | Metacarpophalangeal Joint | 1 | 1993 | 11 | 0.110 |
Why?
| | Environment | 1 | 2015 | 332 | 0.110 |
Why?
| | Amyloidosis | 3 | 1988 | 36 | 0.110 |
Why?
| | Androgen-Insensitivity Syndrome | 1 | 2013 | 5 | 0.110 |
Why?
| | Phosphorus | 1 | 2014 | 82 | 0.110 |
Why?
| | Parathyroid Hormone | 1 | 2014 | 96 | 0.110 |
Why?
| | Reference Values | 4 | 2007 | 743 | 0.110 |
Why?
| | Colorado | 4 | 2010 | 4099 | 0.110 |
Why?
| | Child, Preschool | 7 | 2007 | 9118 | 0.110 |
Why?
| | Healthy Volunteers | 1 | 2014 | 197 | 0.110 |
Why?
| | Calcitriol | 1 | 1993 | 53 | 0.110 |
Why?
| | Random Allocation | 1 | 2014 | 335 | 0.110 |
Why?
| | Growth Inhibitors | 1 | 1993 | 43 | 0.110 |
Why?
| | Prevalence | 3 | 2010 | 2251 | 0.100 |
Why?
| | Wound Healing | 1 | 1995 | 258 | 0.100 |
Why?
| | Time Factors | 12 | 2003 | 6116 | 0.100 |
Why?
| | Radiography | 7 | 2001 | 812 | 0.100 |
Why?
| | Point Mutation | 1 | 2013 | 216 | 0.100 |
Why?
| | Blood Sedimentation | 5 | 2000 | 32 | 0.100 |
Why?
| | Synovitis | 4 | 1993 | 24 | 0.100 |
Why?
| | Leukocytes | 4 | 2002 | 276 | 0.100 |
Why?
| | Acute-Phase Reaction | 2 | 1989 | 39 | 0.100 |
Why?
| | Leucovorin | 2 | 1990 | 43 | 0.100 |
Why?
| | Eye Diseases | 2 | 1992 | 76 | 0.100 |
Why?
| | Receptors, Androgen | 1 | 2013 | 131 | 0.100 |
Why?
| | Carpal Bones | 1 | 1992 | 14 | 0.100 |
Why?
| | Hyperemia | 1 | 1992 | 45 | 0.100 |
Why?
| | Ulna | 1 | 1992 | 25 | 0.100 |
Why?
| | Vitamin D | 2 | 2014 | 341 | 0.100 |
Why?
| | Erythema Nodosum | 1 | 1991 | 3 | 0.100 |
Why?
| | Myocardial Infarction | 2 | 2014 | 927 | 0.100 |
Why?
| | Measles virus | 2 | 1981 | 10 | 0.100 |
Why?
| | Rubella virus | 2 | 1981 | 6 | 0.100 |
Why?
| | Spinal Injuries | 1 | 1992 | 47 | 0.100 |
Why?
| | Vasculitis | 3 | 2001 | 66 | 0.100 |
Why?
| | Red-Cell Aplasia, Pure | 1 | 1991 | 1 | 0.090 |
Why?
| | Reproducibility of Results | 3 | 2007 | 2765 | 0.090 |
Why?
| | Airway Obstruction | 2 | 1996 | 168 | 0.090 |
Why?
| | Interleukin-10 | 2 | 2006 | 299 | 0.090 |
Why?
| | Child | 9 | 2015 | 18420 | 0.090 |
Why?
| | Microbial Collagenase | 1 | 1990 | 10 | 0.090 |
Why?
| | Urinary Tract Infections | 1 | 1992 | 134 | 0.090 |
Why?
| | Treatment Outcome | 10 | 2004 | 9088 | 0.090 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 1992 | 125 | 0.090 |
Why?
| | Anti-Bacterial Agents | 5 | 2003 | 1481 | 0.090 |
Why?
| | Heart Rate | 1 | 2014 | 709 | 0.090 |
Why?
| | Arthritis | 4 | 2000 | 109 | 0.090 |
Why?
| | Digital Rectal Examination | 1 | 2010 | 10 | 0.090 |
Why?
| | Interferon-gamma | 2 | 1990 | 719 | 0.090 |
Why?
| | Occult Blood | 1 | 2010 | 26 | 0.090 |
Why?
| | Testosterone | 1 | 2013 | 343 | 0.090 |
Why?
| | Infant | 6 | 2004 | 7964 | 0.080 |
Why?
| | Receptors, Neurokinin-1 | 1 | 2009 | 12 | 0.080 |
Why?
| | Jaundice | 1 | 1989 | 14 | 0.080 |
Why?
| | Spinal Diseases | 1 | 1990 | 39 | 0.080 |
Why?
| | Diclofenac | 1 | 1989 | 14 | 0.080 |
Why?
| | Intervertebral Disc Displacement | 1 | 1990 | 37 | 0.080 |
Why?
| | Ligaments, Articular | 1 | 1990 | 55 | 0.080 |
Why?
| | Age Factors | 6 | 2015 | 2894 | 0.080 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2009 | 41 | 0.080 |
Why?
| | Temporomandibular Joint Disorders | 1 | 1989 | 8 | 0.080 |
Why?
| | Temporomandibular Joint | 1 | 1989 | 9 | 0.080 |
Why?
| | Aspirin | 2 | 2003 | 324 | 0.080 |
Why?
| | Anemia, Aplastic | 1 | 1989 | 30 | 0.080 |
Why?
| | Biological Factors | 1 | 1989 | 35 | 0.080 |
Why?
| | Cryoglobulinemia | 1 | 1988 | 5 | 0.080 |
Why?
| | Keratosis | 1 | 1988 | 13 | 0.080 |
Why?
| | Familial Mediterranean Fever | 1 | 1988 | 6 | 0.080 |
Why?
| | Ichthyosis | 1 | 1988 | 12 | 0.080 |
Why?
| | Lipopolysaccharides | 2 | 2003 | 823 | 0.080 |
Why?
| | Scleroderma, Systemic | 2 | 2000 | 96 | 0.080 |
Why?
| | Auranofin | 1 | 1988 | 9 | 0.080 |
Why?
| | Adolescent | 12 | 2015 | 17853 | 0.080 |
Why?
| | alpha 1-Antitrypsin | 1 | 2009 | 103 | 0.080 |
Why?
| | Hydrocortisone | 3 | 2001 | 267 | 0.080 |
Why?
| | Immunoglobulins | 1 | 1988 | 143 | 0.080 |
Why?
| | Stomatitis, Aphthous | 1 | 1988 | 10 | 0.080 |
Why?
| | Chyle | 1 | 1988 | 3 | 0.080 |
Why?
| | Seasons | 1 | 2010 | 442 | 0.070 |
Why?
| | Interviews as Topic | 1 | 2010 | 583 | 0.070 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1988 | 71 | 0.070 |
Why?
| | Language | 1 | 2010 | 263 | 0.070 |
Why?
| | Ligaments | 1 | 1988 | 45 | 0.070 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1988 | 120 | 0.070 |
Why?
| | Skin | 5 | 2003 | 655 | 0.070 |
Why?
| | Double-Blind Method | 3 | 2003 | 1660 | 0.070 |
Why?
| | Academic Medical Centers | 1 | 2010 | 411 | 0.070 |
Why?
| | Polychondritis, Relapsing | 1 | 1987 | 2 | 0.070 |
Why?
| | HLA-B27 Antigen | 1 | 2007 | 11 | 0.070 |
Why?
| | Joint Diseases | 1 | 1988 | 59 | 0.070 |
Why?
| | Remission Induction | 3 | 1993 | 233 | 0.070 |
Why?
| | Edema | 1 | 1988 | 119 | 0.070 |
Why?
| | Cysts | 1 | 1988 | 93 | 0.070 |
Why?
| | Chronic Disease | 4 | 2015 | 1578 | 0.070 |
Why?
| | Liver | 2 | 1992 | 1637 | 0.070 |
Why?
| | Demography | 2 | 1999 | 260 | 0.070 |
Why?
| | Blood Proteins | 1 | 1988 | 231 | 0.070 |
Why?
| | Evaluation Studies as Topic | 3 | 1999 | 167 | 0.070 |
Why?
| | Spine | 1 | 1988 | 136 | 0.070 |
Why?
| | Primary Prevention | 1 | 2008 | 172 | 0.070 |
Why?
| | Syndrome | 4 | 1993 | 333 | 0.070 |
Why?
| | Diagnosis, Differential | 4 | 2003 | 1342 | 0.070 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2006 | 20 | 0.070 |
Why?
| | Recombinant Proteins | 3 | 1997 | 1230 | 0.060 |
Why?
| | Monitoring, Physiologic | 2 | 2004 | 249 | 0.060 |
Why?
| | Incidence | 3 | 2002 | 2313 | 0.060 |
Why?
| | Shoulder Joint | 1 | 1988 | 159 | 0.060 |
Why?
| | Isoxazoles | 1 | 2006 | 51 | 0.060 |
Why?
| | Oxygen | 3 | 2003 | 854 | 0.060 |
Why?
| | Culture Techniques | 2 | 1999 | 78 | 0.060 |
Why?
| | Pedigree | 4 | 2000 | 460 | 0.060 |
Why?
| | Sports | 2 | 2015 | 187 | 0.060 |
Why?
| | Kidney | 2 | 2003 | 1188 | 0.060 |
Why?
| | Retrospective Studies | 9 | 2010 | 12554 | 0.060 |
Why?
| | Rheumatoid Factor | 2 | 2001 | 157 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2000 | 1121 | 0.060 |
Why?
| | Inflammation | 3 | 1989 | 2480 | 0.060 |
Why?
| | Cell Division | 4 | 1993 | 758 | 0.060 |
Why?
| | Oximetry | 2 | 2003 | 81 | 0.060 |
Why?
| | Biopsy, Needle | 2 | 1999 | 182 | 0.060 |
Why?
| | Octreotide | 1 | 2004 | 26 | 0.060 |
Why?
| | Crohn Disease | 2 | 2004 | 196 | 0.060 |
Why?
| | Patient Discharge | 1 | 2010 | 772 | 0.060 |
Why?
| | Autoantibodies | 4 | 1999 | 1346 | 0.060 |
Why?
| | Crotonates | 1 | 2003 | 3 | 0.050 |
Why?
| | Toluidines | 1 | 2003 | 6 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 1999 | 4411 | 0.050 |
Why?
| | Tenosynovitis | 1 | 2003 | 12 | 0.050 |
Why?
| | Acne Vulgaris | 3 | 1998 | 20 | 0.050 |
Why?
| | Mycobacterium kansasii | 1 | 2003 | 14 | 0.050 |
Why?
| | Hypnosis | 1 | 1983 | 9 | 0.050 |
Why?
| | Pemphigus | 1 | 1983 | 8 | 0.050 |
Why?
| | Tuberculosis, Miliary | 1 | 2003 | 5 | 0.050 |
Why?
| | Tuberculosis, Cutaneous | 1 | 2003 | 3 | 0.050 |
Why?
| | Carpal Tunnel Syndrome | 1 | 2003 | 27 | 0.050 |
Why?
| | Fasciitis | 1 | 1982 | 10 | 0.050 |
Why?
| | Wakefulness | 1 | 2004 | 128 | 0.050 |
Why?
| | Cell Survival | 2 | 2003 | 1021 | 0.050 |
Why?
| | Lip | 2 | 2001 | 20 | 0.050 |
Why?
| | Lipoproteins | 1 | 1983 | 159 | 0.050 |
Why?
| | Uric Acid | 2 | 2003 | 148 | 0.050 |
Why?
| | History, 20th Century | 1 | 2004 | 264 | 0.050 |
Why?
| | Respiratory Function Tests | 2 | 2003 | 522 | 0.050 |
Why?
| | Tidal Volume | 1 | 2003 | 75 | 0.050 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2003 | 161 | 0.050 |
Why?
| | Technetium Tc 99m Exametazime | 1 | 2002 | 2 | 0.050 |
Why?
| | Spondylarthropathies | 1 | 2002 | 6 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 2 | 2009 | 2086 | 0.050 |
Why?
| | Athletes | 2 | 2015 | 328 | 0.050 |
Why?
| | Nitriles | 1 | 2003 | 149 | 0.050 |
Why?
| | Young Adult | 2 | 2015 | 10471 | 0.050 |
Why?
| | Arthritis, Experimental | 1 | 2004 | 130 | 0.050 |
Why?
| | Radionuclide Imaging | 3 | 2002 | 115 | 0.050 |
Why?
| | Osteoporosis, Postmenopausal | 2 | 2000 | 36 | 0.050 |
Why?
| | Biopsy | 2 | 1999 | 1036 | 0.050 |
Why?
| | Hepatitis B Vaccines | 1 | 2002 | 46 | 0.050 |
Why?
| | Newcastle disease virus | 1 | 1981 | 17 | 0.050 |
Why?
| | Adenoviruses, Human | 1 | 1981 | 24 | 0.050 |
Why?
| | Hepatitis B | 1 | 2002 | 51 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2009 | 493 | 0.050 |
Why?
| | Complement C3b | 1 | 2001 | 30 | 0.050 |
Why?
| | Family Health | 2 | 1994 | 193 | 0.050 |
Why?
| | Movement | 1 | 2004 | 244 | 0.050 |
Why?
| | Radiopharmaceuticals | 1 | 2002 | 157 | 0.050 |
Why?
| | Immunocompromised Host | 1 | 2003 | 195 | 0.050 |
Why?
| | fas Receptor | 1 | 2001 | 91 | 0.050 |
Why?
| | Prednisolone | 2 | 1992 | 75 | 0.050 |
Why?
| | Emergencies | 2 | 1996 | 146 | 0.050 |
Why?
| | United States | 3 | 2008 | 12185 | 0.050 |
Why?
| | Carbon Dioxide | 1 | 2003 | 218 | 0.050 |
Why?
| | Nitroprusside | 1 | 2001 | 64 | 0.050 |
Why?
| | Gastric Antral Vascular Ectasia | 1 | 2000 | 2 | 0.050 |
Why?
| | Cerebrovascular Circulation | 1 | 2003 | 221 | 0.050 |
Why?
| | Hemoglobins | 1 | 2003 | 315 | 0.040 |
Why?
| | Eosinophilia | 1 | 1982 | 186 | 0.040 |
Why?
| | Xanthine | 1 | 2000 | 7 | 0.040 |
Why?
| | Pneumococcal Vaccines | 1 | 2001 | 131 | 0.040 |
Why?
| | Monocytes | 2 | 2001 | 504 | 0.040 |
Why?
| | Xanthine Dehydrogenase | 1 | 2000 | 25 | 0.040 |
Why?
| | Skiing | 1 | 2001 | 42 | 0.040 |
Why?
| | Salivary Glands | 2 | 1997 | 31 | 0.040 |
Why?
| | Leg | 2 | 1996 | 225 | 0.040 |
Why?
| | Anxiety Disorders | 1 | 1983 | 303 | 0.040 |
Why?
| | Sulfur Radioisotopes | 1 | 1999 | 17 | 0.040 |
Why?
| | Haplotypes | 2 | 1992 | 448 | 0.040 |
Why?
| | Lipids | 1 | 1983 | 580 | 0.040 |
Why?
| | Fractures, Stress | 1 | 2000 | 31 | 0.040 |
Why?
| | Glucocorticoids | 2 | 2001 | 532 | 0.040 |
Why?
| | Neck Pain | 1 | 2000 | 24 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2003 | 1226 | 0.040 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 1999 | 29 | 0.040 |
Why?
| | DNA, Viral | 1 | 1981 | 350 | 0.040 |
Why?
| | HLA-DR4 Antigen | 2 | 1992 | 76 | 0.040 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 1999 | 38 | 0.040 |
Why?
| | Age of Onset | 1 | 2001 | 446 | 0.040 |
Why?
| | Sialoglycoproteins | 1 | 2000 | 159 | 0.040 |
Why?
| | Stimulation, Chemical | 2 | 1989 | 56 | 0.040 |
Why?
| | Alkaline Phosphatase | 2 | 1992 | 143 | 0.040 |
Why?
| | Xerostomia | 1 | 1999 | 19 | 0.040 |
Why?
| | Indomethacin | 2 | 1989 | 70 | 0.040 |
Why?
| | Hand Strength | 1 | 2000 | 96 | 0.040 |
Why?
| | Diagnostic Errors | 1 | 2000 | 149 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 1992 | 718 | 0.040 |
Why?
| | Translations | 1 | 1999 | 16 | 0.040 |
Why?
| | Recurrence | 2 | 1992 | 935 | 0.040 |
Why?
| | Sarcoidosis | 1 | 2001 | 135 | 0.040 |
Why?
| | Hemiplegia | 1 | 1998 | 18 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2000 | 122 | 0.040 |
Why?
| | Drug Synergism | 2 | 1990 | 316 | 0.040 |
Why?
| | Lumbosacral Region | 2 | 1990 | 46 | 0.040 |
Why?
| | Infant Behavior | 1 | 1998 | 23 | 0.040 |
Why?
| | Paresis | 1 | 1998 | 28 | 0.040 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2003 | 333 | 0.040 |
Why?
| | Health Status | 2 | 2004 | 722 | 0.040 |
Why?
| | RNA, Viral | 1 | 1981 | 565 | 0.040 |
Why?
| | Prognosis | 2 | 1996 | 3329 | 0.040 |
Why?
| | Appetite | 1 | 1998 | 52 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2004 | 1262 | 0.040 |
Why?
| | Immunoglobulin A, Secretory | 1 | 1997 | 9 | 0.040 |
Why?
| | beta 2-Microglobulin | 1 | 1997 | 45 | 0.040 |
Why?
| | Lactoferrin | 1 | 1997 | 28 | 0.040 |
Why?
| | Electrolytes | 1 | 1997 | 55 | 0.040 |
Why?
| | Polymyalgia Rheumatica | 1 | 1997 | 2 | 0.040 |
Why?
| | Cartilage | 1 | 1999 | 182 | 0.040 |
Why?
| | Respiratory Hypersensitivity | 1 | 1998 | 60 | 0.040 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2002 | 284 | 0.040 |
Why?
| | Folic Acid Antagonists | 1 | 1997 | 8 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 3 | 1998 | 3053 | 0.040 |
Why?
| | Appendicitis | 1 | 1998 | 114 | 0.040 |
Why?
| | Psoriasis | 2 | 2000 | 74 | 0.040 |
Why?
| | Gene Frequency | 2 | 2009 | 477 | 0.030 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 1998 | 98 | 0.030 |
Why?
| | Dermatitis, Allergic Contact | 1 | 1998 | 63 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2002 | 1796 | 0.030 |
Why?
| | Forced Expiratory Flow Rates | 1 | 1996 | 11 | 0.030 |
Why?
| | Cohort Studies | 3 | 1998 | 4895 | 0.030 |
Why?
| | Histocompatibility Testing | 1 | 1997 | 116 | 0.030 |
Why?
| | Risk Assessment | 2 | 2015 | 2968 | 0.030 |
Why?
| | Drug Hypersensitivity | 1 | 1998 | 83 | 0.030 |
Why?
| | Pain Clinics | 1 | 1996 | 3 | 0.030 |
Why?
| | Drug Therapy, Combination | 3 | 2003 | 951 | 0.030 |
Why?
| | Patella | 1 | 1996 | 22 | 0.030 |
Why?
| | Chiropractic | 1 | 1996 | 6 | 0.030 |
Why?
| | Risk Factors | 4 | 2015 | 8632 | 0.030 |
Why?
| | Thromboxane B2 | 1 | 1996 | 26 | 0.030 |
Why?
| | Ribonucleoproteins | 1 | 1997 | 85 | 0.030 |
Why?
| | Menopause | 1 | 1999 | 271 | 0.030 |
Why?
| | Acupuncture Therapy | 1 | 1996 | 18 | 0.030 |
Why?
| | Radioimmunoassay | 1 | 1996 | 162 | 0.030 |
Why?
| | Pilot Projects | 2 | 2004 | 1373 | 0.030 |
Why?
| | Adrenergic beta-Agonists | 1 | 1996 | 126 | 0.030 |
Why?
| | Mouth Diseases | 1 | 1996 | 40 | 0.030 |
Why?
| | Wilderness Medicine | 1 | 2015 | 12 | 0.030 |
Why?
| | Mutation | 2 | 2009 | 3346 | 0.030 |
Why?
| | Poliovirus Vaccine, Inactivated | 1 | 1995 | 22 | 0.030 |
Why?
| | Poliomyelitis | 1 | 1995 | 27 | 0.030 |
Why?
| | Abdomen | 2 | 2002 | 99 | 0.030 |
Why?
| | Reference Standards | 1 | 1995 | 159 | 0.030 |
Why?
| | Thrombophlebitis | 1 | 1995 | 8 | 0.030 |
Why?
| | Maintenance and Engineering, Hospital | 1 | 1994 | 2 | 0.030 |
Why?
| | Macrophages | 1 | 2001 | 1263 | 0.030 |
Why?
| | Rectum | 1 | 1995 | 153 | 0.030 |
Why?
| | Cholesterol | 2 | 1988 | 367 | 0.030 |
Why?
| | Angiography | 1 | 1995 | 174 | 0.030 |
Why?
| | Blotting, Western | 1 | 1997 | 1147 | 0.030 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 3 | 1999 | 33 | 0.030 |
Why?
| | Autoantigens | 1 | 1997 | 396 | 0.030 |
Why?
| | Pregnancy | 3 | 2015 | 5520 | 0.030 |
Why?
| | Parents | 1 | 2002 | 1186 | 0.030 |
Why?
| | 24,25-Dihydroxyvitamin D 3 | 1 | 1993 | 2 | 0.030 |
Why?
| | Semen Analysis | 1 | 2013 | 10 | 0.030 |
Why?
| | Sperm Count | 1 | 2013 | 16 | 0.030 |
Why?
| | Sperm Injections, Intracytoplasmic | 1 | 2013 | 7 | 0.030 |
Why?
| | Food Hypersensitivity | 1 | 1998 | 251 | 0.030 |
Why?
| | Ischemia | 1 | 1996 | 362 | 0.030 |
Why?
| | Rats | 3 | 2004 | 4958 | 0.030 |
Why?
| | Analgesics | 1 | 1995 | 158 | 0.030 |
Why?
| | Infertility, Male | 1 | 2013 | 59 | 0.030 |
Why?
| | Hyperostosis, Sternocostoclavicular | 1 | 1993 | 1 | 0.030 |
Why?
| | Collagenases | 1 | 1993 | 22 | 0.030 |
Why?
| | Linear Models | 1 | 1995 | 768 | 0.030 |
Why?
| | Sleep | 1 | 1998 | 632 | 0.030 |
Why?
| | Apoptosis | 1 | 2001 | 2363 | 0.030 |
Why?
| | Cervical Atlas | 1 | 1992 | 4 | 0.030 |
Why?
| | Axis, Cervical Vertebra | 1 | 1992 | 7 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 262 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 1995 | 669 | 0.020 |
Why?
| | Respiratory Tract Diseases | 1 | 1993 | 138 | 0.020 |
Why?
| | Transaminases | 1 | 1992 | 24 | 0.020 |
Why?
| | Radius | 1 | 1992 | 33 | 0.020 |
Why?
| | Blood Urea Nitrogen | 2 | 2003 | 51 | 0.020 |
Why?
| | Collagen | 2 | 1991 | 415 | 0.020 |
Why?
| | Atmosphere Exposure Chambers | 1 | 1991 | 6 | 0.020 |
Why?
| | Serotyping | 1 | 1991 | 28 | 0.020 |
Why?
| | Pain | 2 | 2001 | 705 | 0.020 |
Why?
| | Infant, Premature | 1 | 1995 | 476 | 0.020 |
Why?
| | Hyperbaric Oxygenation | 1 | 1991 | 36 | 0.020 |
Why?
| | Kidney Function Tests | 2 | 2003 | 140 | 0.020 |
Why?
| | Disease Models, Animal | 2 | 2004 | 3535 | 0.020 |
Why?
| | Logistic Models | 1 | 1996 | 1841 | 0.020 |
Why?
| | Adaptation, Physiological | 1 | 1995 | 483 | 0.020 |
Why?
| | Drug Antagonism | 1 | 1990 | 8 | 0.020 |
Why?
| | Crystallization | 2 | 1988 | 136 | 0.020 |
Why?
| | Anticoagulants | 1 | 1995 | 550 | 0.020 |
Why?
| | Dyspnea | 1 | 1992 | 211 | 0.020 |
Why?
| | Antibody Formation | 3 | 2002 | 266 | 0.020 |
Why?
| | Self Concept | 1 | 1991 | 214 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 1995 | 2218 | 0.020 |
Why?
| | Spinal Stenosis | 1 | 1990 | 24 | 0.020 |
Why?
| | Asthma | 3 | 2003 | 2029 | 0.020 |
Why?
| | Drug Combinations | 1 | 1990 | 287 | 0.020 |
Why?
| | Smoking | 1 | 1996 | 1383 | 0.020 |
Why?
| | Etidronic Acid | 2 | 1999 | 3 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 1989 | 198 | 0.020 |
Why?
| | Mandibular Condyle | 1 | 1989 | 5 | 0.020 |
Why?
| | Infant, Newborn | 3 | 2013 | 5047 | 0.020 |
Why?
| | Congo Red | 1 | 1988 | 8 | 0.020 |
Why?
| | Accidents | 1 | 1989 | 39 | 0.020 |
Why?
| | Raynaud Disease | 1 | 1988 | 5 | 0.020 |
Why?
| | HLA-A Antigens | 2 | 1993 | 49 | 0.020 |
Why?
| | Point-of-Care Systems | 1 | 2010 | 136 | 0.020 |
Why?
| | HLA-B35 Antigen | 1 | 1988 | 3 | 0.020 |
Why?
| | Azathioprine | 2 | 1992 | 49 | 0.020 |
Why?
| | Periarthritis | 1 | 1988 | 1 | 0.020 |
Why?
| | Immunoglobulin G | 2 | 2001 | 770 | 0.020 |
Why?
| | Staining and Labeling | 1 | 1988 | 134 | 0.020 |
Why?
| | Serum Amyloid P-Component | 1 | 1987 | 3 | 0.020 |
Why?
| | Calcium Phosphates | 1 | 1988 | 24 | 0.020 |
Why?
| | Coronary Disease | 2 | 1995 | 348 | 0.020 |
Why?
| | Vaccination | 1 | 1995 | 1204 | 0.020 |
Why?
| | Complement C4 | 1 | 1987 | 25 | 0.020 |
Why?
| | Population | 1 | 2007 | 28 | 0.020 |
Why?
| | Odds Ratio | 1 | 2009 | 953 | 0.020 |
Why?
| | Alleles | 1 | 2009 | 789 | 0.020 |
Why?
| | Accidental Falls | 1 | 1989 | 151 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 1988 | 216 | 0.020 |
Why?
| | Aging | 1 | 2015 | 1618 | 0.020 |
Why?
| | Iran | 2 | 2000 | 36 | 0.020 |
Why?
| | Hereditary Sensory and Autonomic Neuropathies | 1 | 1985 | 3 | 0.020 |
Why?
| | Radiography, Thoracic | 1 | 1986 | 150 | 0.020 |
Why?
| | Cytokines | 2 | 1990 | 1841 | 0.010 |
Why?
| | Adipose Tissue | 1 | 1988 | 545 | 0.010 |
Why?
| | Pyoderma Gangrenosum | 1 | 2004 | 5 | 0.010 |
Why?
| | Animals | 6 | 2004 | 31708 | 0.010 |
Why?
| | Rats, Inbred Lew | 1 | 2004 | 91 | 0.010 |
Why?
| | Infliximab | 1 | 2004 | 94 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 2004 | 116 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 1991 | 1737 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2009 | 1177 | 0.010 |
Why?
| | Debridement | 1 | 2003 | 73 | 0.010 |
Why?
| | Bone Marrow Examination | 1 | 1982 | 6 | 0.010 |
Why?
| | Hypergammaglobulinemia | 1 | 1982 | 9 | 0.010 |
Why?
| | Finger Joint | 1 | 1982 | 7 | 0.010 |
Why?
| | Splenomegaly | 1 | 1982 | 17 | 0.010 |
Why?
| | Measles Vaccine | 1 | 1982 | 17 | 0.010 |
Why?
| | Hepatitis B Antibodies | 1 | 2002 | 10 | 0.010 |
Why?
| | Hepatitis B Surface Antigens | 1 | 2002 | 18 | 0.010 |
Why?
| | Proteinuria | 1 | 1982 | 77 | 0.010 |
Why?
| | Serologic Tests | 1 | 2002 | 49 | 0.010 |
Why?
| | Myositis | 1 | 1982 | 44 | 0.010 |
Why?
| | Phospholipids | 1 | 1983 | 197 | 0.010 |
Why?
| | Measles | 1 | 1982 | 38 | 0.010 |
Why?
| | Elbow Joint | 1 | 1982 | 59 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2009 | 1880 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2003 | 332 | 0.010 |
Why?
| | Arthritis, Infectious | 1 | 1982 | 49 | 0.010 |
Why?
| | Opsonin Proteins | 1 | 2001 | 25 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 1983 | 316 | 0.010 |
Why?
| | Triglycerides | 1 | 1983 | 467 | 0.010 |
Why?
| | Chondrocalcinosis | 1 | 2001 | 2 | 0.010 |
Why?
| | Receptors, Complement | 1 | 2001 | 111 | 0.010 |
Why?
| | Clinical Chemistry Tests | 1 | 2001 | 9 | 0.010 |
Why?
| | Occupations | 1 | 2001 | 36 | 0.010 |
Why?
| | Hematologic Tests | 1 | 2001 | 22 | 0.010 |
Why?
| | Antibodies, Bacterial | 1 | 2001 | 119 | 0.010 |
Why?
| | Reoperation | 1 | 2003 | 514 | 0.010 |
Why?
| | Thyroid Diseases | 1 | 2001 | 30 | 0.010 |
Why?
| | Anemia, Hypochromic | 1 | 2000 | 2 | 0.010 |
Why?
| | Ankle Joint | 1 | 1982 | 153 | 0.010 |
Why?
| | Therapeutic Equivalency | 1 | 2000 | 18 | 0.010 |
Why?
| | Pneumococcal Infections | 1 | 2001 | 91 | 0.010 |
Why?
| | Histocompatibility Antigens Class II | 1 | 1982 | 352 | 0.010 |
Why?
| | Thymus Gland | 1 | 2001 | 296 | 0.010 |
Why?
| | Amino Acid Sequence | 2 | 2000 | 1982 | 0.010 |
Why?
| | Polymorphism, Single-Stranded Conformational | 1 | 2000 | 25 | 0.010 |
Why?
| | Laser Coagulation | 1 | 2000 | 54 | 0.010 |
Why?
| | Placebos | 1 | 2000 | 197 | 0.010 |
Why?
| | Furosemide | 1 | 2000 | 32 | 0.010 |
Why?
| | Microsatellite Repeats | 1 | 2000 | 136 | 0.010 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2000 | 102 | 0.010 |
Why?
| | Diuretics | 1 | 2000 | 66 | 0.010 |
Why?
| | Folic Acid | 2 | 1990 | 161 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2000 | 294 | 0.010 |
Why?
| | Serum Sickness | 1 | 1999 | 7 | 0.010 |
Why?
| | Endoscopy, Digestive System | 1 | 2000 | 110 | 0.010 |
Why?
| | Neoplasms | 1 | 1993 | 2097 | 0.010 |
Why?
| | Calcitonin | 1 | 1999 | 23 | 0.010 |
Why?
| | Hepatitis, Autoimmune | 1 | 1999 | 27 | 0.010 |
Why?
| | Serum Albumin | 1 | 2000 | 137 | 0.010 |
Why?
| | Antibodies, Anticardiolipin | 1 | 1998 | 5 | 0.010 |
Why?
| | Iatrogenic Disease | 1 | 1999 | 49 | 0.010 |
Why?
| | Gene Expression | 1 | 2004 | 1421 | 0.010 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2000 | 254 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2000 | 511 | 0.010 |
Why?
| | Appendectomy | 1 | 1998 | 67 | 0.010 |
Why?
| | Arthralgia | 1 | 1998 | 46 | 0.010 |
Why?
| | Kinetics | 1 | 2001 | 1551 | 0.010 |
Why?
| | Estrogen Replacement Therapy | 1 | 1999 | 116 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 2000 | 321 | 0.010 |
Why?
| | Functional Laterality | 1 | 1998 | 198 | 0.010 |
Why?
| | Laparotomy | 1 | 1998 | 103 | 0.010 |
Why?
| | Cell Aggregation | 2 | 1988 | 24 | 0.010 |
Why?
| | Occupational Diseases | 1 | 1998 | 128 | 0.010 |
Why?
| | Sacroiliac Joint | 1 | 1997 | 30 | 0.010 |
Why?
| | Skin Diseases, Vascular | 1 | 1996 | 8 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2004 | 2553 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2003 | 3003 | 0.010 |
Why?
| | Base Sequence | 1 | 2000 | 2114 | 0.010 |
Why?
| | Peroxidase | 1 | 1996 | 163 | 0.010 |
Why?
| | Sex Factors | 1 | 2001 | 1715 | 0.010 |
Why?
| | Infant Welfare | 1 | 1995 | 4 | 0.010 |
Why?
| | Bone Density | 1 | 1999 | 432 | 0.010 |
Why?
| | Vaccines, Inactivated | 1 | 1995 | 68 | 0.010 |
Why?
| | Spirometry | 1 | 1995 | 224 | 0.010 |
Why?
| | Europe | 1 | 1994 | 334 | 0.010 |
Why?
| | Body Mass Index | 1 | 2000 | 1959 | 0.010 |
Why?
| | Osteomyelitis | 1 | 1993 | 105 | 0.010 |
Why?
| | Necrosis | 1 | 1972 | 211 | 0.010 |
Why?
| | Endopeptidases | 1 | 1990 | 71 | 0.010 |
Why?
| | Prostheses and Implants | 1 | 1972 | 137 | 0.010 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 1991 | 127 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2003 | 2096 | 0.010 |
Why?
| | Lymphoma | 1 | 1990 | 177 | 0.010 |
Why?
| | Depression, Chemical | 1 | 1989 | 22 | 0.010 |
Why?
| | Interleukin-2 | 1 | 1990 | 413 | 0.010 |
Why?
| | Drug Interactions | 1 | 1990 | 338 | 0.010 |
Why?
| | Health Promotion | 1 | 1995 | 686 | 0.010 |
Why?
| | Mice | 3 | 1990 | 14871 | 0.000 |
Why?
| | Immunity, Cellular | 1 | 1990 | 248 | 0.000 |
Why?
| | Tumor Cells, Cultured | 1 | 1990 | 849 | 0.000 |
Why?
| | Lung Diseases | 1 | 1995 | 701 | 0.000 |
Why?
| | Multiple Trauma | 1 | 1989 | 96 | 0.000 |
Why?
| | Arthrography | 1 | 1988 | 22 | 0.000 |
Why?
| | Injections, Subcutaneous | 1 | 1987 | 134 | 0.000 |
Why?
| | Iodine Radioisotopes | 1 | 1987 | 125 | 0.000 |
Why?
| | Tissue Distribution | 1 | 1987 | 286 | 0.000 |
Why?
| | Hemodynamics | 1 | 1991 | 1012 | 0.000 |
Why?
| | Hypertension | 1 | 1995 | 1056 | 0.000 |
Why?
| | Cell Adhesion | 1 | 1988 | 432 | 0.000 |
Why?
| | Suicide, Attempted | 1 | 1989 | 317 | 0.000 |
Why?
| | Poland | 1 | 1985 | 29 | 0.000 |
Why?
| | Bacterial Infections | 1 | 1987 | 218 | 0.000 |
Why?
| | Virus Diseases | 1 | 1987 | 195 | 0.000 |
Why?
| | Amyloid | 1 | 1985 | 80 | 0.000 |
Why?
| | Vitreous Body | 1 | 1985 | 101 | 0.000 |
Why?
| | Preoperative Care | 1 | 1986 | 319 | 0.000 |
Why?
| | Tuberculosis | 1 | 1986 | 241 | 0.000 |
Why?
| | HLA-DR1 Antigen | 1 | 1982 | 1 | 0.000 |
Why?
| | Injections, Intra-Articular | 1 | 1982 | 43 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1982 | 362 | 0.000 |
Why?
| | Lung Neoplasms | 1 | 1986 | 2177 | 0.000 |
Why?
| | Methods | 1 | 1972 | 58 | 0.000 |
Why?
| | Knee | 1 | 1972 | 51 | 0.000 |
Why?
|
|
Yaron's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|